Amit Hazan
Stock Analyst at Goldman Sachs
(2.12)
# 2,850
Out of 4,900 analysts
95
Total ratings
56.25%
Success rate
1.33%
Average return
Main Sectors:
Stocks Rated by Amit Hazan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | n/a | $128.00 | - | 3 | Dec 13, 2022 | |
| BVS Bioventus | Maintains: Neutral | $13 → $2.5 | $6.61 | -62.15% | 5 | Nov 30, 2022 | |
| SKIN The Beauty Health Company | Maintains: Buy | $22 → $19 | $1.64 | +1,058.54% | 4 | Nov 23, 2022 | |
| SHC Sotera Health Company | Maintains: Neutral | $9 → $8 | $11.38 | -29.70% | 4 | Nov 23, 2022 | |
| LIVN LivaNova | Maintains: Buy | $73 → $63 | $43.43 | +45.06% | 3 | Nov 23, 2022 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $319 → $272 | $178.31 | +52.54% | 8 | Nov 23, 2022 | |
| BLCO Bausch + Lomb | Maintains: Neutral | $19 → $17 | $13.71 | +24.00% | 3 | Nov 23, 2022 | |
| OM Outset Medical | Maintains: Buy | $510 → $435 | $18.08 | +2,306.64% | 2 | Nov 9, 2022 | |
| PRCT PROCEPT BioRobotics | Maintains: Neutral | $39 → $44 | $58.01 | -24.15% | 2 | Nov 4, 2022 | |
| EW Edwards Lifesciences | Maintains: Neutral | $97 → $73 | $76.81 | -4.96% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $60 → $53 | $28.25 | +87.61% | 11 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $57 | $30.90 | +84.47% | 1 | Oct 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $9.5 | $10.71 | -11.30% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $111 → $104 | $131.49 | -20.91% | 7 | Jul 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $60 | $12.22 | +391.00% | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $129 → $115 | $89.22 | +28.89% | 9 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $248 → $150 | $390.59 | -61.60% | 2 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $46 | $103.48 | -55.55% | 1 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $242 | $512.23 | -52.82% | 8 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $177 | $94.03 | +88.24% | 5 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $147 | $155.17 | -5.27% | 6 | Feb 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $3.5 → $3.9 | $1.33 | +193.23% | 3 | Nov 1, 2018 |
Inspire Medical Systems
Dec 13, 2022
Upgrades: Buy
Price Target: n/a
Current: $128.00
Upside: -
Bioventus
Nov 30, 2022
Maintains: Neutral
Price Target: $13 → $2.5
Current: $6.61
Upside: -62.15%
The Beauty Health Company
Nov 23, 2022
Maintains: Buy
Price Target: $22 → $19
Current: $1.64
Upside: +1,058.54%
Sotera Health Company
Nov 23, 2022
Maintains: Neutral
Price Target: $9 → $8
Current: $11.38
Upside: -29.70%
LivaNova
Nov 23, 2022
Maintains: Buy
Price Target: $73 → $63
Current: $43.43
Upside: +45.06%
Becton, Dickinson and Company
Nov 23, 2022
Maintains: Buy
Price Target: $319 → $272
Current: $178.31
Upside: +52.54%
Bausch + Lomb
Nov 23, 2022
Maintains: Neutral
Price Target: $19 → $17
Current: $13.71
Upside: +24.00%
Outset Medical
Nov 9, 2022
Maintains: Buy
Price Target: $510 → $435
Current: $18.08
Upside: +2,306.64%
PROCEPT BioRobotics
Nov 4, 2022
Maintains: Neutral
Price Target: $39 → $44
Current: $58.01
Upside: -24.15%
Edwards Lifesciences
Nov 3, 2022
Maintains: Neutral
Price Target: $97 → $73
Current: $76.81
Upside: -4.96%
Nov 3, 2022
Maintains: Sell
Price Target: $60 → $53
Current: $28.25
Upside: +87.61%
Oct 11, 2022
Initiates: Buy
Price Target: $57
Current: $30.90
Upside: +84.47%
Aug 8, 2022
Maintains: Neutral
Price Target: $11 → $9.5
Current: $10.71
Upside: -11.30%
Jul 25, 2022
Maintains: Sell
Price Target: $111 → $104
Current: $131.49
Upside: -20.91%
Jul 14, 2022
Maintains: Neutral
Price Target: $80 → $60
Current: $12.22
Upside: +391.00%
Jan 18, 2022
Maintains: Neutral
Price Target: $129 → $115
Current: $89.22
Upside: +28.89%
Apr 1, 2020
Downgrades: Sell
Price Target: $248 → $150
Current: $390.59
Upside: -61.60%
Feb 13, 2020
Initiates: Neutral
Price Target: $46
Current: $103.48
Upside: -55.55%
Feb 13, 2020
Initiates: Buy
Price Target: $242
Current: $512.23
Upside: -52.82%
Feb 13, 2020
Initiates: Buy
Price Target: $177
Current: $94.03
Upside: +88.24%
Feb 25, 2019
Maintains: Neutral
Price Target: $139 → $147
Current: $155.17
Upside: -5.27%
Nov 1, 2018
Upgrades: Neutral
Price Target: $3.5 → $3.9
Current: $1.33
Upside: +193.23%